Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting A North-American perspective

被引:167
作者
Faxon, David P. [1 ]
Eikelboom, John W. [2 ,3 ]
Berger, Peter B. [4 ]
Holmes, David R. [5 ]
Bhatt, Deepak L. [6 ]
Moliterno, David J. [7 ,8 ]
Becker, Richard C. [9 ,10 ]
Angiolillo, Dominick J. [11 ]
机构
[1] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02120 USA
[2] Hamilton Hlth Sci, Dept Med, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA
[5] Mayo Clin, Rochester, MN USA
[6] VA Boston Hlth Syst, Div Cardiol, Boston, MA USA
[7] Univ Kentucky, Gill Heart Inst, Lexington, KY USA
[8] Univ Kentucky, Div Cardiovasc Med, Lexington, KY USA
[9] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA
[10] Duke Univ, Sch Med, Div Hematol, Durham, NC USA
[11] Univ Florida, Div Cardiol, Coll Med Jacksonville, Jacksonville, FL USA
关键词
Atrial fibrillation; antithrombotic therapy; warfarin; triple therapy; stent; DUAL ANTIPLATELET THERAPY; ACCF/AHA/HRS FOCUSED UPDATE; CARDIOLOGY WORKING GROUP; RHYTHM ASSOCIATION EHRA; PROTON-PUMP INHIBITORS; LOW-DOSE ASPIRIN; ELUTING STENT; BARE-METAL; MYOCARDIAL-INFARCTION; ORAL ANTICOAGULANT;
D O I
10.1160/TH11-04-0262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The optimal regimen of the anticoagulant and antiplatelet therapies in patients with atrial fibrillation who have had a coronary stent is unclear. It is well recognised that "triple therapy" with aspirin, clopidogrel, and warfarin is associated with an increased risk of bleeding. National guidelines have not made specific recommendations given the lack of adequate data. In choosing the best antithrombotic options for a patient, consideration needs to be given to the risks of stroke, stent thrombosis and major bleeding. This document describes these risks, provides specific recommendations concerning vascular access, stent choice, concomitant use of proton-pump inhibitors and the use and duration of triple therapy following stent placement based upon the risk assessment.
引用
收藏
页码:572 / 584
页数:13
相关论文
共 99 条
[1]   ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents [J].
Abraham, Neena S. ;
Hlatky, Mark A. ;
Antman, Elliott M. ;
Bhatt, Deepak L. ;
Bjorkman, David J. ;
Clark, Craig B. ;
Furberg, Curt D. ;
Johnson, David A. ;
Kahi, Charles J. ;
Laine, Loren ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Scheiman, James ;
Sperling, Laurence S. ;
Tomaselli, Gordon F. ;
Harrington, Robert A. ;
Bates, Eric R. ;
Bhatt, Deepak L. ;
Ferrari, Victor A. ;
Fisher, John D. ;
Gardner, Timothy J. ;
Gentile, Federico ;
Hlatky, Mark A. ;
Jacobs, Alice K. ;
Kaul, Sanjay ;
Moliterno, David J. ;
Weitz, Howard H. ;
Wesley, Deborah J. .
CIRCULATION, 2010, 122 (24) :2619-2633
[2]   New oral anticoagulant drugs in cardiovascular disease [J].
Ahrens, Ingo ;
Lip, Gregory Y. H. ;
Peter, Karlheinz .
THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) :49-60
[3]   Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [J].
Airoldi, Flavio ;
Colombo, Antonio ;
Morici, Nuccia ;
Latib, Azeem ;
Cosgrave, John ;
Buellesfeld, Lutz ;
Bonizzoni, Erminio ;
Carlino, Mauro ;
Gerckens, Ulrich ;
Godino, Cosmo ;
Melzi, Gloria ;
Michev, Iassen ;
Montorfano, Matteo ;
Sangiorgi, Giuseppe Massimo ;
Qasim, Asif ;
Chieffo, Alaide ;
Briguori, Carlo ;
Grube, Eberhard .
CIRCULATION, 2007, 116 (07) :745-754
[4]   Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].
Alexander, John H. ;
Becker, Richard C. ;
Bhatt, Deepak L. ;
Cools, Frank ;
Crea, Filippo ;
Dellborg, Mikael ;
Fox, Keith A. A. ;
Goodman, Shaun G. ;
Harrington, Robert A. ;
Huber, Kurt ;
Husted, Steen ;
Lewis, Basil S. ;
Lopez-Sendon, Jose ;
Mohan, Puneet ;
Montalescot, Gilles ;
Ruda, Mikhail ;
Ruzyllo, Witold ;
Verheugt, Freek ;
Wallentin, Lars ;
Darius, Harald ;
Simoons, Maarten ;
Boersma, Eric ;
DeLemos, James ;
Spencer, Fred .
CIRCULATION, 2009, 119 (22) :2877-U39
[5]  
ANATA P, 2011, ANN INTERN MED, V154, P500
[6]   Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation [J].
Anderson, Jeffrey L. ;
Horne, Benjamin D. ;
Stevens, Scott M. ;
Grove, Amanda S. ;
Barton, Stephanie ;
Nicholas, Zachery P. ;
Kahn, Samera F. S. ;
May, Heidi T. ;
Samuelson, Kent M. ;
Muhlestein, Joseph B. ;
Carlquist, John F. .
CIRCULATION, 2007, 116 (22) :2563-2570
[7]  
ANDERSON JL, 2011, CIRCULATION IN PRESS
[8]   Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies [J].
Angiolillo, D. J. ;
Gibson, C. M. ;
Cheng, S. ;
Ollier, C. ;
Nicolas, O. ;
Bergougnan, L. ;
Perrin, L. ;
LaCreta, F. P. ;
Hurbin, F. ;
Dubar, M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (01) :65-74
[9]   Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study [J].
Angiolillo, Dominick J. ;
Shoemaker, Steven B. ;
Desai, Bhaloo ;
Yuan, Hang ;
Charlton, Ronald K. ;
Bernardo, Esther ;
Zenni, Martin M. ;
Guzman, Luis A. ;
Bass, Theodore A. ;
Costa, Marco A. .
CIRCULATION, 2007, 115 (06) :708-716
[10]   Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives [J].
Angiolillo, Dominick J. ;
Fernandez-Ortiz, Antonio ;
Bernardo, Esther ;
Alfonso, Fernando ;
Macaya, Carlos ;
Bass, Theodore A. ;
Costa, Marco A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) :1505-1516